It may be possible to safely prevent one of the most common - and costly to treat - infections contracted by hospitalized patients undergoing bone marrow transplantation for the treatment of blood cancers, according to a ...
Nov 28, 2016
0
0
Harvard University has completed a license agreement with Magenta Therapeutics, a new startup company launched in Cambridge, for a portfolio of technologies with the potential to transform blood stem cell transplants from ...
Nov 16, 2016
0
0
Certain DNA mutations in bone cells that support blood development can drive leukemia formation in nearby blood stem cells, researchers from Winship Cancer Institute, Emory University and Children's Healthcare of Atlanta ...
Oct 26, 2016
0
4
The innate immune system serves as a first-line defense, responding to infections almost immediately after a pathogen makes its way into the body. This response is carried out in two major ways: the cell can amplify the message ...
Oct 14, 2016
0
6
A pioneering new trial offers new hope in the fight against HIV after a patient treated with a new therapy appears to have no trace of the virus in their blood. Although experts remain cautious, this novel treatment may allow ...
Oct 7, 2016
0
167
(Medical Xpress)—British newspaper The Sunday Times is reporting that a team of researchers in the U.K. believe they may have cured a man that was HIV positive. If the claims turn out to be true, it would mark the first ...
A new type of immunotherapy shows promise against cases of acute myeloid leukemia (AML) that recur after treatment or that never respond to therapy in the first place. A small clinical trial at Washington University School ...
Sep 21, 2016
0
41
(HealthDay)—Umbilical cord blood may work as well as current alternatives for adults and children with leukemia—or even better in some cases, according to a study published in the Sept. 8 issue of the New England Journal ...
Sep 8, 2016
0
2
Due to significant advances in diagnosis and treatment, many Australians with cancer can expect to survive and lead a normal life. For those of reproductive age this includes the chance to have their own family in the future. ...
Aug 26, 2016
0
0
New research has shown how a cell surface molecule, Lymphotoxin β receptor, controls entry of T-cells into the thymus; and as such presents an opportunity to understanding why cancer patients who undergo bone-marrow transplant ...
Aug 25, 2016
0
0
